Health ❯ Cancer ❯ Prostate Cancer

Treatment Options

Surgery Hormone-Sensitive Cancer Palliative Care Active Surveillance Radiotherapy Radiation Therapy Side Effects Long-term Functional Outcomes Radical Prostatectomy Mental Health Management Strategies Public Awareness Aggressive Forms Cancer Research Hormone Therapy Awareness and Research Hospice Care Early Detection Remission Radioligand Therapy Overtreatment Alternative Treatments Hormonal Therapy Experimental Drugs Interventions Aspirin Experimental Treatments FDA-Approved Drugs Patient Perspectives Alternative Therapies Outcomes Favorable Prognosis Unfavorable Prognosis

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

The deal would bring Halda’s RIPTAC technology plus prostate cancer pill HLD-0915 under J&J pending antitrust clearance.